Skip to main content

Geron Corp

GERN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000886744

In the last 90 days, Geron Corp insiders filed 2 open-market purchases and 0 sales; 261 institutions reported holding it in 13F filings for Q2 2026, worth $610.5M in total; no superinvestor holds it.

Key figures

Market capClose on Nov 17, 2026
$644.2M
Insider buysLast 90 days, $62.1K in total
2
Insider sellsOpen market, last 90 days
0
13F holdersQ2 2026, +6 vs. previous quarter
261
13F valueReported value at the end of Q2 2026
$610.5M
Superinvestors holdingAt the end of Q2 2026
0

Price chart

From SEC filings, in USD.

Revenue, FY2025
–
No comparable prior period
Net income, FY2025
-$83.5M
No comparable prior period
Free cash flow, FY2025
–
No comparable prior period
Revenue, Q3 FY2026
$60.2M
+27.4% year over year

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest
67.0M
Shares sold short
Change
−7.66M
−10.3% vs. previous
Days to cover
3.92
At average daily volume

Superinvestors holding GERN, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding GERN at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by Geron Corp insiders from Form 4, newest first.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 16, 2026 (view filing)4:30 PM ETNov 16Same dayWilliams TimothyEVP and Chief Legal OfficerPPurchase+12.0K$0.94+$11.3KNew position12.0K after
Nov 16, 2026 (view filing)4:30 PM ETNov 133 daysSemerjian HaroutPresident & CEOPPurchase+53.5K$0.95+$50.8KNew position53.5K after
Feb 19, 2026 (view filing)Feb 181 dayRobertson MichelleEVP, CHIEF FINANCIAL OFFICERSSale−9.86K$1.94−$19.1K−35.8%17.6K after
May 13, 2025 (view filing)May 94 daysLawlis V BryanDirectorPPurchase+13.3K$1.18+$15.7KNew position13.3K after
Mar 3, 2025 (view filing)Feb 274 daysSamuels Scott AlanEVP, Chief Legal OfficerPPurchase+15.0K$1.61+$24.1K+128.4%26.7K after
Mar 3, 2025 (view filing)Feb 274 daysScarlett John AChairman, President and CEOPPurchase+12.5K$1.77+$22.1KNew position12.5K after
Mar 3, 2025 (view filing)Feb 274 daysZiegler JamesEVP, Chief Commercial OfficerPPurchase+100.0K$1.60+$160.0KNew position100.0K after
Jul 10, 2024 (view filing)Jul 82 daysGrethlein Andrew JEVP, Chief Operating OfficerSSale−674.3K$4.56−$3.08M−100.0%0 after
Jun 12, 2024 (view filing)Jun 102 daysFeller FayeEVP, Chief Medical OfficerSSale−287.9K$4.63−$1.33M−100.0%0 after
Jun 12, 2024 (view filing)Jun 102 daysKapur AnilEVP, Corp Strategy & CCOSSale−421.9K$4.65−$1.96M−100.0%0 after

Top 10 13F holders, Q2 2026

See all 261 holders

The largest institutional positions in Geron Corp at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding GERN in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
BlackRock, Inc.49,115,571$62.9M0.00%+1,795,792+3.8%Added
Ra Capital Management, L.P.42,809,751$54.8M0.48%−20,961,615−32.9%Reduced
Soleus Capital Management, L.P.42,808,659$54.8M1.89%+1,300,000+3.1%Added
State Street Corp35,856,671$45.9M0.00%+5,359,488+17.6%Added
Citadel Advisors LLC29,038,928$37.2M0.02%+7,462,359+34.6%Added
Vanguard Capital Management LLC27,250,215$34.9M0.00%+581,186+2.2%Added
Clearbridge Investments, LLC19,648,853$25.2M0.02%+28,533+0.1%Added
Eversept Partners, LP18,717,422$24.0M1.31%−117,461−0.6%Reduced
Goldman Sachs Group Inc16,633,368$21.3M0.00%+5,456,777+48.8%Added
Geode Capital Management, LLC14,555,954$18.6M0.00%+885,169+6.5%Added

Holders of 5% or more of GERN

See all 3 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Geron Corp.

Largest holders of GERN from 13D and 13G filings
HolderLatest formStakeChangeFirst filedLatest filingFiling
Ra Capital Management, L.P.13G/A9.90%66.5M shares0.00 ppfrom 9.90%Feb 16, 20217 filingsAug 14, 2026SEC
Soleus Capital Master Fund, L.P.13G/A6.50%41.5M shares+1.30 ppfrom 5.20%Mar 3, 20262 filingsMay 8, 2026SEC
State Street Corp13G5.00%31.9M shares−0.60 ppfrom 5.60%Feb 1, 20234 filingsNov 10, 2026SEC